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on Calciﬁed Nodule
Ex Vivo Intravascular Images and HistopathologyRika Kawakami, MD,* Hiroyuki Hao, MD,* Yaemi Takagi, MD,* Akiko Fujino, MD,* Yasu-aki Tsuchida, MD,*
Takahiro Imanaka, MD,y Kenichi Fujii, MD,y Seiichi Hirota, MD*A 70-year-old woman was admitted to our hos-pital due to cardiogenic shock and died ofheart failure 1 day after admission. She had
a 12-year history of hemodialysis. Biodegradable-
polymer biolimus-eluting stent (NOBORI, Terumo
Corporation, Tokyo, Japan) was implanted in the
left anterior descending artery 2 months before. An
autopsy was performed, and ex vivo intravascular
ultrasound (Terumo Corp.), optical frequency domain
imaging (Terumo Corp.), and coronary angioscopy
(FiberTech, Tokyo, Japan) were examined.FIGURE 1 Ex Vivo Intravascular Imaging of Calciﬁed Nodule 2 Month
(A) Intravascular ultrasound demonstrated a hypoechoic mass undernea
illustrated a high-backscattering protruding mass with signal attenuation
were visible by coronary angioscopy (arrows).
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imaging, and coronary angioscopy demonstrated a
hypoechoic mass (Figure 1A), a high backscattering
protruding mass with signal attenuation (Figure 1B),
and a yellowish protrusion with uneven strut ex-
pansion (Figure 1C), respectively, at the stent-
implanted region. Neointima coverage was minimal,
and struts were visible. Histology demonstrated a
large calciﬁed nodule (CN) (1) underneath the
stent struts (Figure 2A). A healthy vessel wall was
stretched with medial necrosis and nearly ruptured bys After Biolimus-Eluting Stent Implantation
th the stent struts (arrows). (B) Optical frequency domain imaging
(arrows). (C) A yellowish protrusion mass was observed and the struts
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FIGURE 2 Pathology After Biolimus-Eluting Stent Implantation on a Calciﬁed Nodule
(A) A calciﬁed protruding mass was observed underneath the stent struts. (B) The struts nearly reached to the adventitia at the healthy
vessel wall (arrows). Loose extracellular matrix (C) and a-smooth muscle actin-positive spindle-shaped cells (D) were identiﬁed within the
neointima. (A to C) Hematoxylin eosin. (D) a-Smooth muscle actin. (A) Scale bar ¼ 1 mm. (B) High magniﬁcation view of left lower boxed area
in A. Scale bar ¼ 200 mm. (C, D) High magniﬁcation view of right upper boxed area in A. Scale bar ¼ 100 mm. AD ¼ adventitia; M ¼ media;
NI ¼ neointima.
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e128stent implantation (Figure 2B). Most of the stent
struts were covered by minimal neointima with
loose extracellular matrix (Figure 2C) and scattered
a-smooth muscle actin-positive spindle-shaped cells
(Figure 2D).
The target lesion calciﬁcation is an important
determinant of the expansion of stent (2). A CN hardly
expands by the tensile strength of stent deployment.
In fact, the stent area was insufﬁcient in the presentcase. Furthermore, a healthy vessel wall might be
overstretched and rupture during the intervention.
We need to exercise every precaution for an inter-
vention of a CN.
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